Uncovering the first FDA-approved drug for Ebola virus infection
US scientists have outlined the structure and function of the first FDA approved drug for the Ebola virus.
List view / Grid view
US scientists have outlined the structure and function of the first FDA approved drug for the Ebola virus.
US researchers found that serotonin impacts the mitral valve in the heart which can lead to heart valve disease.
A US pre-clinical study investigating the antidepressant: MAP4343, discovered it reduced alcohol intake in a mouse model of alcoholism.
Japanese researchers find a new mechanism for how the measles virus can cause a rare but fatal neurological disorder: subacute sclerosing panencephalitis (SSPE).
An AI strategy developed by US scientists could accelerate the development of new antibody drugs.
Chronic pain often leads to depression, which US researchers have potentially solved using a mechanism involved with ketamine.
US researchers discovered a type of cell involved it pancreatic cancer and sheds light on the origin of cancer-associated fibroblasts (CAFs).
Japanese scientists analyse the associative synaptic plasticity in the supramammillary nucleus–dentate gyrus pathways.
Scientists from Rice University are using fluorescence lifetime to shed new light on a peptide associated with Alzheimer’s disease.
Researchers have found a potential therapeutic target less vulnerable to potential drug resistance and emerging COVID-19 variants of concern.
US researchers will use a unique combination of imaging techniques (MRI and MSI) to study Alzheimer’s disease on a scale that has never been done before.
US research about immunological memory may help development of potential vaccines or immunotherapies for cancer and various inflammatory diseases.
US researchers use new imaging technique to see cardiac reactions to noradrenaline, the ‘fight or flight’ hormone.
US researchers revealed that MRSA has undergone repeated mutations in the sarZ gene, leading to increased severity of blood stream infections in mouse models.
US researchers discover a potential therapeutic avenue through the molecule NgR2, against an aggressive form of prostate cancer.